Expression Profiling of N6-methyladenosine-modified MRNA in PC12 Cells in Response to Unconjugated Bilirubin

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2023 Jun 28

PMID 37378749

Authors

Jinfu Zhou

Sining Liao

Chenran Zhang

Jinying Luo

Guilin Li

Huangyuan Li

Affiliations

Soon will be listed here.

Abstract

Background: Abnormal methylation of N-methyladenosine (mA) is reportedly associated with central nervous system disorders. However, the role of mA mRNA methylation in unconjugated bilirubin (UCB) neurotoxicity requires further research.

Methods: Rat pheochromocytoma PC12 cells treated with UCB were used as in vitro models. After the PC12 cells were treated with UCB (0, 12, 18, and 24 µM) for 24 h, the total RNA mA levels were measured using an mA RNA methylation quantification kit. The expression of m6A demethylases and methyltransferases was detected through western blotting. We determined the mA mRNA methylation profile in PC12 cells exposed to UCB (0 and 18 µM) for 24 h using methylated RNA immunoprecipitation sequencing (MeRIP-seq).

Results: Compared with the control group, UCB (18 and 24 µM) treatment decreased the expression of the mA demethylase ALKBH5 and increased the expression of the methyltransferases METTL3 and METTL14, which resulted in an increase in the total mA levels in PC12 cells. Furthermore, 1533 mA peaks were significantly elevated and 1331 peaks were reduced in the UCB (18 µM)-treated groups compared with those in the control group. Genes with differential mA peaks were mainly enriched in protein processing in the endoplasmic reticulum, ubiquitin-mediated proteolysis, cell cycle, and endocytosis. Through combined analysis of the MeRIP-seq and RNA sequencing data, 129 genes with differentially methylated mA peaks and differentially expressed mRNA levels were identified.

Conclusion: Our study suggests that the modulation of mA methylation modifications plays a significant role in UCB neurotoxicity.

References

Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson P . Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 2011; 128(4):e925-31. PMC: 3182847. DOI: 10.1542/peds.2011-0206. View

Kaplan M, Bromiker R, Hammerman C . Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity. Semin Perinatol. 2014; 38(7):429-37. DOI: 10.1053/j.semperi.2014.08.006. View

Bortolussi G, Codarin E, Antoniali G, Vascotto C, Vodret S, Arena S . Impairment of enzymatic antioxidant defenses is associated with bilirubin-induced neuronal cell death in the cerebellum of Ugt1 KO mice. Cell Death Dis. 2015; 6:e1739. PMC: 4669693. DOI: 10.1038/cddis.2015.113. View

Rauti R, Qaisiya M, Tiribelli C, Ballerini L, Bellarosa C . Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: a new pathway of neurotoxicity. Arch Toxicol. 2020; 94(3):845-855. DOI: 10.1007/s00204-020-02659-9. View

Calligaris R, Bellarosa C, Foti R, Roncaglia P, Giraudi P, Krmac H . A transcriptome analysis identifies molecular effectors of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells. BMC Genomics. 2009; 10:543. PMC: 2789749. DOI: 10.1186/1471-2164-10-543. View

Schiavon E, Smalley J, Newton S, Greig N, Forsythe I . Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model. PLoS One. 2018; 13(8):e0201022. PMC: 6091913. DOI: 10.1371/journal.pone.0201022. View

Barateiro A, Vaz A, Silva S, Fernandes A, Brites D . ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin. Neuromolecular Med. 2012; 14(4):285-302. DOI: 10.1007/s12017-012-8187-9. View

Qaisiya M, Mardesic P, Pastore B, Tiribelli C, Bellarosa C . The activation of autophagy protects neurons and astrocytes against bilirubin-induced cytotoxicity. Neurosci Lett. 2017; 661:96-103. DOI: 10.1016/j.neulet.2017.09.056. View

Feng J, Li M, Wei Q, Li S, Song S, Hua Z . Unconjugated bilirubin induces pyroptosis in cultured rat cortical astrocytes. J Neuroinflammation. 2018; 15(1):23. PMC: 5776766. DOI: 10.1186/s12974-018-1064-1. View

10.

Gou P, Qi X, Yuan R, Li H, Gao X, Wang J . Tet1-mediated DNA demethylation involves in neuron damage induced by bilirubin in vitro. Toxicol Mech Methods. 2017; 28(1):55-61. DOI: 10.1080/15376516.2017.1357775. View

11.

Vianello E, Zampieri S, Marcuzzo T, Tordini F, Bottin C, Dardis A . Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat. Sci Rep. 2018; 8(1):13690. PMC: 6135864. DOI: 10.1038/s41598-018-32106-w. View

12.

Lv J, Xing L, Zhong X, Li K, Liu M, Du K . Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents. Biomed Pharmacother. 2023; 162:114583. DOI: 10.1016/j.biopha.2023.114583. View

13.

Lu Z, Liu J, Yuan C, Jin M, Quan K, Chu M . mA mRNA methylation analysis provides novel insights into heat stress responses in the liver tissue of sheep. Genomics. 2020; 113(1 Pt 2):484-492. DOI: 10.1016/j.ygeno.2020.09.038. View

14.

Wang Q, Liang Y, Luo X, Liu Y, Zhang X, Gao L . N6-methyladenosine RNA modification: A promising regulator in central nervous system injury. Exp Neurol. 2021; 345:113829. DOI: 10.1016/j.expneurol.2021.113829. View

15.

Sokpor G, Xie Y, Nguyen H, Tuoc T . Emerging Role of m A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment. Front Cell Dev Biol. 2021; 9:656849. PMC: 8170044. DOI: 10.3389/fcell.2021.656849. View

16.

Yen Y, Chen J . The mA epitranscriptome on neural development and degeneration. J Biomed Sci. 2021; 28(1):40. PMC: 8157406. DOI: 10.1186/s12929-021-00734-6. View

17.

Du T, Li G, Yang J, Ma K . RNA demethylase Alkbh5 is widely expressed in neurons and decreased during brain development. Brain Res Bull. 2020; 163:150-159. DOI: 10.1016/j.brainresbull.2020.07.018. View

18.

Shafik A, Zhang F, Guo Z, Dai Q, Pajdzik K, Li Y . N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer's disease. Genome Biol. 2021; 22(1):17. PMC: 7786910. DOI: 10.1186/s13059-020-02249-z. View

19.

Zhang N, Ding C, Zuo Y, Peng Y, Zuo L . N6-methyladenosine and Neurological Diseases. Mol Neurobiol. 2022; 59(3):1925-1937. DOI: 10.1007/s12035-022-02739-0. View

20.

Wang N, Xiao H, Lu H, Chen K, Zhang S, Liu F . Effect of PI3K/AKT/mTOR signaling pathway-based clustered nursing care combined with papaverine injection on vascular inflammation and vascular crisis after replantation of severed fingers. Mol Cell Biochem. 2023; 479(6):1525-1534. PMC: 11224086. DOI: 10.1007/s11010-023-04796-y. View